
Prime Therapeutics Receives 2009 TIPPS Certification
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management,
announced today its 2009 Transparency in Pharmaceutical Purchasing Standards (TIPPS) certification.
Prime Therapeutics Connects Physicians to Mail Order Pharmacy
through SureScripts-RxHub Network
Prime Therapeutics, a thought leader in pharmacy benefit management, announced
today that it has completed certification with SureScripts-RxHub.
Prime Therapeutics Releases Annual Drug Trend Insights Report
Prime Therapeutics, a thought leader in pharmacy benefit management, today released its
2008 Drug Trend Insights report which revealed that its 2007 prescription drug trend increased by just
2.9 percent — the lowest annual increase it ever recorded, and less than half of what the company
recorded in 2006.
Prime Therapeutics Supports CMS Proposal to Limit Spread Pricing in Medicare Part D Administration
Prime Therapeutics (Prime) today commented on CMS’s recently released proposal
to require "spread pricing" by pharmacy benefits managers (PBMs) to be appropriately
accounted for and reported as administrative costs.
Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
Prime Therapeutics (Prime) announced today the hiring of Jerry Steffl as Vice
President, Government Affairs
Prime Therapeutics Receives VIPPS Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management,
announced today that it has received accreditation from the National Association of Boards of
Pharmacy® (NABP®) through its Verified Internet Pharmacy Practice Sites™ (VIPPS®)
Program.
Prime Therapeutics Providing Full-Service
Pharmacy Benefit Management Services to Blue Cross and Blue Shield of Oklahoma
Prime Therapeutics (Prime) announced today that it has begun providing
new services for its Blue Cross and Blue Shield of Oklahoma client. These new services mark
the beginning of Blue Cross and Blue Shield of Oklahoma as a full-service client of Prime.
Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management,
announced today that Rachelle Wan, RPh, has joined the organization as Vice President of Pharmacy Trade Relations.
Increased Out-of-Pocket Expenses May Negatively Influence
Initiation of TNF Blocker Therapy
Prime Therapeutics (Prime), a thought leader in pharmacy benefit
management, today announced the results of its study, "Association Between Tumor Necrosis
Factor (TNF) Blocker Out-of-Pocket (OOP) Expense and Member Decline to Fill Rate".
Prime Therapeutics Introduces Triessent Specialty Pharmacy Program
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, recently announced the
launch of its specialty pharmacy program, Triessent.
Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
Prime Therapeutics launches the Efficiency Program, a targeted approach to value-based pharmacy management, that helps employers understand how to spend their limited health care dollars in ways that are most beneficial to the health of their employees.
Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation
Prime Therapeutics (Prime) has joined the Center for Health Value Innovation as the first participant from the pharmacy benefit management (PBM) industry.
Safety Concerns Prompt Prime to Remove Avandia® from Formulary
Pharmacy benefit manager Prime Therapeutics (Prime) recently announced the removal of the prescription drug Avandia® from its national formulary. After careful examination of clinical literature regarding the safety and efficacy of Avandia, Prime's National Pharmacy and Therapeutics (P&T) Committee has made the decision to remove the drug from its formulary. Prime's P&T Committee is a panel of pharmacists and physicians that meets quarterly and reviews drugs for Prime's formulary.
Prime Therapeutics Hires Charles Roehrick as Chief Financial Officer
Prime Therapeutics (Prime), a nationwide pharmacy benefit management company, recently announced that Charles Roehrick has joined the organization as Chief Financial Officer.
Prime Therapeutics Hires Will Lambert as Vice President of Provider Network Services
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Will Lambert has joined the organization as Vice President of Provider Network Services.
Prime Therapeutics Contracts with Blue Shield of California
Prime Therapeutics LLC (Prime) has entered into an agreement with Blue Shield of California (Blue Shield) to provide Blue Shield's mail pharmacy services, beginning January 1, 2008.
Prime Therapeutics Announces URAC Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today it has achieved URAC Pharmacy Benefit Management (PBM) accreditation.
Prime Therapeutics Receives TIPPS Certification
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today its 2008 Transparency in Pharmaceutical Purchasing Standards SM (TIPPS SM) certification.
Prime Therapeutics Hires Erin Ascher as Vice President of Human Resources
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Erin Ascher has joined the organization as Vice President of Human Resources.
Prime Therapeutics Releases 2006 Drug Trend Insights
For the fourth consecutive year, Prime Therapeutics (Prime) reported a single digit drug trend increase for 2006. According to the pharmacy benefit management company's 2006 Drug Trend Insights, released today, Prime had a 5.9 percent increase for overall drug spending in 2006.
Prime Hires Arthur Palileo as Vice President of Enterprise Program Management and Integration
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that Arthur Palileo has joined the organization as Vice President of Enterprise Program Management and Integration.
Prime Therapeutics Announces Participation in URAC Accreditation
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today their participation in URAC's efforts to create a pharmacy benefit management (PBM) accreditation program for the commercial markets.
Prime Therapeutics Promotes Kim Mageau to Chief Operating Officer
Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today the promotion of Kim Mageau to Chief Operating Officer.
Study Shows Children with ADHD who Start on Strattera® are More Likely to Change Therapies
Pharmacy benefit manager Prime Therapeutics (Prime) today announced the results of a study on the utilization of Strattera® (atomoxetine) for treating attention deficit hyperactivity disorder (ADHD) in children.
Study finds 90 Percent of Actiq® "Lollipop" Prescriptions are Off-label
A recent Prime Therapeutics (Prime) study found significant patterns of "off-label" prescribing for Actiq® among patients taking the powerful painkilling "lollipop." Prescribing Actiq according to FDA guidelines is important for patient safety reasons because of the drug's serious side effects, including its addictive nature.
(651) 414-1525
(800) 858-0723 ext 1525
Western Conference
External Operations Conference
InterContinental Mark Hopkins Hotel
San Francisco, CA
Please stop by the Prime booth in the exhibit area.
Blue Cross and Blue Shield Association
Spring Health IT and Architecture Forum
Renaissance Orlando Resort at Sea World
Orlando, FL
John Beardsley, Prime’s Vice President of Strategic Marketing and Product Development, will be participating in a panel discussion about e-prescribing.
America’s Health Insurance Plans
Institute 2008
Moscone Center West
San Francisco, CA
Christine Solberg, PharmD, BCPS, Prime’s Associate Vice President of Clinical Products and Benefit Strategy, will be speaking about value-based benefit design.
World Congress
3rd Annual Executive Forum on Rx Benefit Management for Employers and Health Plans
Rio All Suite Hotel and Casino
Las Vegas, NV
Christine Solberg, PharmD, BCPS, Prime’s Associate Vice President of Clinical Products and Benefit Strategy, will be speaking about value-based benefit design.